HOME STRATEGY TEAM PORTFOLIO NEWS CONTACT US  

Harald Ekman

David V. Goeddel, Ph.D.

Richard Klausner, M.D.

Magnus Persson, M.D., Ph.D.

Peter Svennilson

David Baltimore, Ph.D.

Michael S. Brown, M.D.

Joseph L. Goldstein, M.D.

Tom Maniatis, Ph.D.

Tim Kutzkey, Ph.D.

Gregory S. Naeve, Ph.D.

Dee Datta, Ph.D.

Grant Heidrich

The Column Group will primarily focus on early stage drug discovery companies, an area currently underserved by many biotech venture capital funds. Each of these companies will comprise a "Big Idea" backed by outstanding science with strong therapeutic pipeline potential. We will invest in 10-12 companies per fund, with the understanding that innovative and compelling ideas, as well as the top scientific and management talent are rare.